Claudin-5 dysfunction has also been implicated in many neurological disorders, including Alzheimer’s disease, multiple sclerosis, stroke, epilepsy, and schizophrenia (34). This evidence concerns the gene CLDN5 and early-onset autosomal dominant Alzheimer disease.